No link between Merck's Gardasil and MS risk, study shows

Merck's Gardasil HPV vaccine--FierceBiotech file photo
Merck's Gardasil

Merck ($MRK) and partner Sanofi ($SNY) can breathe easy: According to a new study, their blockbuster HPV shot Gardasil isn't linked to an increased risk of multiple sclerosis. In a study published Tuesday in JAMA, researchers found that in a population of 3.9 million girls and women, those vaccinated with Gardasil had lower rates of MS and similar CNS diseases. Story

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.